Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Nina Wagner"'
Autor:
Edina Komlodi-Pasztor, Marta Escarra-Senmarti, Danielle A. Bazer, Aastha Bhatnagar, Carlos A. Perez Heydrich, Marcus Messmer, Richard F. Ambinder, Douglas E. Gladstone, Laura Clayton, Amy Goodrich, Laura Schoch, Nina Wagner-Johnston, Christopher J. VandenBussche, Peng Huang, Matthias Holdhoff, Maximillian Rosario
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
The monoclonal antibody rituximab improves clinical outcome in the treatment of CD20-positive lymphomatous neoplasms, and it is an established drug for treatment of these cancers. Successful mRNA COVID-19 (SARS-CoV-2) vaccination is extremely importa
Externí odkaz:
https://doaj.org/article/231eb2a41b7d476ea9cd7853570c0c4f
Autor:
Samantha L. Vogt, Moosa Patel, Atul Lakha, Vinitha Philip, Tanvier Omar, Philippa Ashmore, Sugeshnee Pather, Lisa M. Haley, Gang Zheng, Jennifer Stone, Elizabeth Mayne, Wendy Stevens, Nina Wagner-Johnston, Christopher D. Gocke, Neil A. Martinson, Richard F. Ambinder, Rena R. Xian
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 611-621 (2021)
PURPOSEDiagnosis of AIDS lymphoma in low-resource settings, like South Africa, is often delayed, leaving patients with limited treatment options. In tuberculosis (TB) endemic regions, overlapping signs and symptoms often lead to diagnostic delays. As
Externí odkaz:
https://doaj.org/article/a13f57b2b79345a29f25b7e23e037256
Autor:
Philip H. Imus, Hua-Ling Tsai, Leo Luznik, Ephraim J. Fuchs, Carol Ann Huff, Douglas E. Gladstone, Patrick Lowery, Richard F. Ambinder, Ivan M. Borrello, Lode J. Swinnen, Nina Wagner-Johnston, Christian B. Gocke, Syed Abbas Ali, F.Javier Bolaños-Meade, Ravi Varadhan, Richard J. Jones
Publikováno v:
Blood Advances, Vol 3, Iss 17, Pp 2608-2616 (2019)
Abstract: Hematologic malignancies in older people are unlikely to be cured with chemotherapy alone. Advances in allogeneic blood or marrow transplantation (alloBMT), especially nonmyeloablative (NMA) conditioning and the use of haploidentical donors
Externí odkaz:
https://doaj.org/article/197de5e065234acea249f8b75efa3cfa
Autor:
Alison, Sehgal, Daanish, Hoda, Peter A, Riedell, Nilanjan, Ghosh, Mehdi, Hamadani, Gerhard C, Hildebrandt, John E, Godwin, Patrick M, Reagan, Nina, Wagner-Johnston, James, Essell, Rajneesh, Nath, Scott R, Solomon, Rebecca, Champion, Edward, Licitra, Suzanne, Fanning, Neel, Gupta, Ronald, Dubowy, Aleco, D'Andrea, Lei, Wang, Ken, Ogasawara, Jerill, Thorpe, Leo I, Gordon
Publikováno v:
The Lancet Oncology. 23:1066-1077
Patients with relapsed or refractory large B-cell lymphoma after first-line treatment who are not intended for haematopoietic stem-cell transplantation (HSCT) have poor outcomes and limited treatment options. We assessed the antitumour activity and s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7048a30eddf5ad18755f1aba03ca478
https://doi.org/10.1016/s1470-2045(22)00339-4
https://doi.org/10.1016/s1470-2045(22)00339-4
Autor:
William G. Wierda, Jennifer Brown, Jeremy S. Abramson, Farrukh Awan, Syed F. Bilgrami, Greg Bociek, Danielle Brander, Asher A. Chanan-Khan, Steve E. Coutre, Randall S. Davis, Herbert Eradat, Christopher D. Fletcher, Sameh Gaballa, Armin Ghobadi, Muhammad Saad Hamid, Francisco Hernandez-Ilizaliturri, Brian Hill, Paul Kaesberg, Manali Kamdar, Lawrence D. Kaplan, Nadia Khan, Thomas J. Kipps, Shuo Ma, Anthony Mato, Claudio Mosse, Stephen Schuster, Tanya Siddiqi, Deborah M. Stephens, Chaitra Ujjani, Nina Wagner-Johnston, Jennifer A. Woyach, J. Christine Ye, Mary A. Dwyer, Hema Sundar
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:622-634
The treatment landscape of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) has significantly evolved in recent years. Targeted therapy with Bruton’s tyrosine kinase (BTK) inhibitors and BCL-2 inhibitors has emerged as an effective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30c8aded1262cbc6543928cc2785abf8
https://doi.org/10.6004/jnccn.2022.0031
https://doi.org/10.6004/jnccn.2022.0031
Autor:
Amy E. DeZern, Alexander J. Ambinder, Matthew D. Smith, Carol Ann Huff, Christian B. Gocke, Douglas E. Gladstone, Gabriel Ghiaur, William Dalton, Philip H. Imus, Mark J. Levis, Lukasz P. Gondek, Jonathan Webster, Ivana Gojo, Gabrielle T. Prince, Tania Jain, Margaret M. Showel, Ivan Borrello, Ravi Varadhan, Javier Bolaños-Meade, Hua-Ling Tsai, B. Douglas Smith, Nina Wagner-Johnston, Leo Luznik, Syed Abbas Ali, Richard Jones, Richard F. Ambinder, Ephraim J. Fuchs, Lode J. Swinnen
Publikováno v:
Clin Lymphoma Myeloma Leuk
Introduction Mutations in the IDH1 or IDH2 genes are detected in approximately 20% of cases of acute myeloid leukemia (AML). Few studies have examined the impact of IDH mutations in AML on allogeneic bone marrow transplant (alloBMT) outcomes. Patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0215195cbf6b25e9d8a024fa569e52ce
https://doi.org/10.1016/j.clml.2021.09.022
https://doi.org/10.1016/j.clml.2021.09.022
Autor:
Ian D. Lewis, Dale Song, Pierre Fustier, Patrick Hagner, Anjan Thakurta, Jacqueline Russo, Chih-Jian Lih, P. Mickey Williams, Yandan Yang, Louis M. Staudt, George W. Wright, Pier Luigi Zinzani, Thomas E. Witzig, Gilles Salles, Francisco J. Hernandez-Ilizaliturri, David A. Eberhard, Pierre Brousset, Graham W. Slack, Randy D. Gascoyne, Nina Wagner-Johnston, Kim M. Linton, Simon Rule, Andrew Davies, Marek Trněný, Myron S. Czuczman
Investigator's Choice (IC) Dosing Regimens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0b054c13e02bc6939aaccf418b66f26
https://doi.org/10.1158/1078-0432.22467816.v1
https://doi.org/10.1158/1078-0432.22467816.v1
Autor:
Ian D. Lewis, Dale Song, Pierre Fustier, Patrick Hagner, Anjan Thakurta, Jacqueline Russo, Chih-Jian Lih, P. Mickey Williams, Yandan Yang, Louis M. Staudt, George W. Wright, Pier Luigi Zinzani, Thomas E. Witzig, Gilles Salles, Francisco J. Hernandez-Ilizaliturri, David A. Eberhard, Pierre Brousset, Graham W. Slack, Randy D. Gascoyne, Nina Wagner-Johnston, Kim M. Linton, Simon Rule, Andrew Davies, Marek Trněný, Myron S. Czuczman
DLC-001 Study Design (CONSORT diagram)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37d43c841cbd16021e370b7dac47965b
https://doi.org/10.1158/1078-0432.22467819.v1
https://doi.org/10.1158/1078-0432.22467819.v1
Autor:
Ian D. Lewis, Dale Song, Pierre Fustier, Patrick Hagner, Anjan Thakurta, Jacqueline Russo, Chih-Jian Lih, P. Mickey Williams, Yandan Yang, Louis M. Staudt, George W. Wright, Pier Luigi Zinzani, Thomas E. Witzig, Gilles Salles, Francisco J. Hernandez-Ilizaliturri, David A. Eberhard, Pierre Brousset, Graham W. Slack, Randy D. Gascoyne, Nina Wagner-Johnston, Kim M. Linton, Simon Rule, Andrew Davies, Marek Trněný, Myron S. Czuczman
Grade 3/4 Treatment-Emergent Adverse Events Reported in {greater than or equal to}5% of Patients (Safety Population)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ce38777ac003610402bca9a9548b9fa
https://doi.org/10.1158/1078-0432.22467810
https://doi.org/10.1158/1078-0432.22467810
Autor:
Ian D. Lewis, Dale Song, Pierre Fustier, Patrick Hagner, Anjan Thakurta, Jacqueline Russo, Chih-Jian Lih, P. Mickey Williams, Yandan Yang, Louis M. Staudt, George W. Wright, Pier Luigi Zinzani, Thomas E. Witzig, Gilles Salles, Francisco J. Hernandez-Ilizaliturri, David A. Eberhard, Pierre Brousset, Graham W. Slack, Randy D. Gascoyne, Nina Wagner-Johnston, Kim M. Linton, Simon Rule, Andrew Davies, Marek Trněný, Myron S. Czuczman
List of Primer Sequences
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::975e2378e6dccb27379e1aa520357118
https://doi.org/10.1158/1078-0432.22467813.v1
https://doi.org/10.1158/1078-0432.22467813.v1